Pancreatic Neuroendocrine Neoplasm Clinical Trials in Buffalo, New York

Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Carcinomas